These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8220829)

  • 1. [The body's nonspecific resistance factors in a localized experimental infection caused by Bacteroides].
    Tyshko AG; Bebko IuM
    Mikrobiol Z; 1993; 55(4):64-8. PubMed ID: 8220829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of humoral factors in host resistance to the Bacteroides fragilis group.
    Bjornson AB
    Rev Infect Dis; 1990; 12 Suppl 2():S161-8. PubMed ID: 2406868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of opsonins for Bacteroides fragilis in immune sera collected from experimentally infected mice.
    Ellis TM; Barrett JT
    Infect Immun; 1982 Mar; 35(3):929-36. PubMed ID: 7068222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pentameric structure of IgM is necessary to enhance opsonization of Bacteroides thetaiotaomicron and Bacteroides fragilis via the alternative complement pathway.
    Bjornson AB; Detmers PA
    Microb Pathog; 1995 Aug; 19(2):117-28. PubMed ID: 8577235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complement in host resistance against members of the Bacteroidaceae.
    Bjornson AB
    Rev Infect Dis; 1984; 6 Suppl 1():S34-9. PubMed ID: 6718942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The gnotobiologic approach to the study of the body's non-specific resistance to infection].
    Podoprigora GI
    Arkh Patol; 1976; 38(3):77-85. PubMed ID: 1275791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anti-Bacteroides-antibodies on Escherichia coli and different Bacteroides species in vitro and vivo.
    Rodloff AC; Hilliger F; Friedman H; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):483-91. PubMed ID: 3541458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional and systemic immune responses in a murine model of empyema.
    Naziri W; Appel S; Trachtenberg L; Polk HC
    Surg Gynecol Obstet; 1993 Oct; 177(4):361-5. PubMed ID: 8211579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonspecific resistance in germ-free and E. coli monocontaminated miniature piglets].
    Podoprigora GI
    Biull Eksp Biol Med; 1978 Sep; 86(9):341-4. PubMed ID: 359062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune T cells prevent bacteroides fragilis abscesses.
    Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
    Curr Surg; 1983; 40(2):123-6. PubMed ID: 6602035
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental Bacteroides fragilis bacteremia in a primate model: evidence that Bacteroides fragilis does not promote the septic shock syndrome.
    Simon GL; Gelfand JA; Connolly RA; O'Donnell TF; Gorbach SL
    J Trauma; 1985 Dec; 25(12):1156-62. PubMed ID: 4068069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of complement in innate, adaptive and eosinophil-dependent immunity to the nematode Nippostrongylus brasiliensis.
    Giacomin PR; Gordon DL; Botto M; Daha MR; Sanderson SD; Taylor SM; Dent LA
    Mol Immunol; 2008 Jan; 45(2):446-55. PubMed ID: 17675237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of intraabdominal abscess formation: abscess-potentiating agents and inhibition of complement-dependent opsonization of abscess-inducing bacteria.
    Finlay-Jones JJ; Kenny PA; Nulsen MF; Spencer LK; Hill NL; McDonald PJ
    J Infect Dis; 1991 Dec; 164(6):1173-9. PubMed ID: 1659600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies to Bacteroides antigens in the blood serum].
    Tyshko AG; Fal' MM; Fal' NI; Marchenko NN; Smol'nikova LI
    Vrach Delo; 1984 Feb; (2):111-2. PubMed ID: 6144208
    [No Abstract]   [Full Text] [Related]  

  • 16. The capsular polysaccharide complex of Bacteroides fragilis induces cytokine production from human and murine phagocytic cells.
    Gibson FC; Tzianabos AO; Onderdonk AB
    Infect Immun; 1996 Mar; 64(3):1065-9. PubMed ID: 8641762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of phagocytosis of E. coli by B. fragilis group--an in vitro study.
    Beena VK; Kumari N; Shivananda PG
    Indian J Pathol Microbiol; 1997 Jul; 40(3):373-6. PubMed ID: 9354011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demonstration of agglutinating antibodies in bacteroides infections].
    Herrmann B; Nowak W
    Z Gesamte Hyg; 1976; 22(10):759-62. PubMed ID: 997630
    [No Abstract]   [Full Text] [Related]  

  • 19. Difficulties in the serodiagnosis of infection with the fragilis group of Bacteroides.
    Elhag KM; Bahar AM; Mahajan KK
    J Med Microbiol; 1987 Sep; 24(2):125-31. PubMed ID: 3309321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complement in milk and defense of the bovine mammary gland against infections.
    Rainard P
    Vet Res; 2003; 34(5):647-70. PubMed ID: 14556699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.